Der Report
Tiefgehende Einblicke in Unternehmensfinanzierung, Wachstumsstrategien und Markterkenntnisse der innovativsten Unternehmen der Welt
67 Berichte und es werden mehr
Graphite Bio Raises $238M in Series B
Graphite Bio, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $238M in Series B at a $1B valuation led by ARCH Venture Partners, Vida Ventures, Norwest Venture Partners, Samsara BioCapital.
Graphite Bio raises $238M Series B at $1B valuation
Graphite Bio raises $238M in Series B at $1B valuation. Precision genetic medicines...
Syntis Bio Raises $33M in Series A
Syntis Bio, a HealthTech company based in Cambridge, MA, has raised $33M in Series A led by Cerberus Ventures.
Verdiva Bio Raises $411M in Series A
Verdiva Bio, a Biotech company based in Cambridge, MA, has raised $411M in Series A at a $1.5B valuation led by Atlas Venture, Polaris Partners.
Orbillion Bio Raises $15M in Seed
Orbillion Bio, a FoodTech company based in San Francisco, CA, has raised $15M in Seed at a $50M valuation led by At One Ventures, New Crop Capital.
Nura Bio Raises $68M in Series A
Nura Bio, a Biotech company based in South San Francisco, CA, has raised $68M in Series A at a $300M valuation led by Atlas Venture, Deerfield Management.
Braveheart Bio Raises $185 million in Series A
Braveheart Bio, a Biotechnology company based in San Francisco CA, has raised $185 million in Series A at a Undisclosed led by Andreessen Horowitz.
Pivot Bio Raises $430M in Series D
Pivot Bio, a Biotech company based in Berkeley, CA, has raised $430M in Series D at a $2B valuation led by DCVC, Temasek.
Upstream Bio Raises $153M in Series B
Upstream Bio, a Biotech company based in Waltham, MA, has raised $153M in Series B at a $800M valuation led by Fidelity, Viking Global.
9 Berichte angezeigt • Seite 1 • Kategorie: all
Bleiben Sie dem Markt voraus
Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.